Status:

COMPLETED

COVID-19 Serologic Strategies for Skilled Nursing Facilities

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

Brown University

National Institute on Aging (NIA)

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Staff Stakeholders:
  • Must be employees of ArchCare
  • Must be members of included unit staff or those that float on those designated units
  • Willing to participate in focus groups or semi-structured interviews with study team
  • Inclusion Criteria for Family Participants:
  • Family members of residents who reside at either TCC or MMW (ArchCare facilities)
  • Family member of resident who is on designated study unit or eligible to be transferred to such unit
  • Willing to participate in focus groups or semi-structured interviews with study team
  • Inclusion Criteria for Resident Participants:
  • Resident has ability to communicate and follow simple commands
  • Resident has ability to communicate and follow simple commands
  • English- or Spanish-speaking
  • Resident has capacity to consent assessed with standard questions used to assess capacity or having a surrogate who can provide consent.
  • Must agree to have serologic testing for COVID-19
  • Agrees to remain on one of the facility units of study or to be transferred to such unit
  • Exclusion Criteria for Staff Stakeholders:
  • Not employees of ArchCare
  • Not members of included unit staff or those that float on those designated units
  • Not willing to participate in focus groups or semi-structured interviews with study team
  • Exclusion Criteria for Family Participants:
  • Not family members of residents who reside at either TCC or MMW (ArchCare facilities)
  • Not family member of resident who is on designated study unit or eligible to be transferred to such unit
  • Not willing to participate in focus groups or semi-structured interviews with study team
  • Exclusion Criteria for Resident Participants:
  • Resident is not living in the unit of intervention
  • Resident does not have ability to communicate and follow simple commands
  • Not English- or Spanish-speaking
  • Resident lacks capacity to consent assessed with standard questions used to assess capacity and does not have a surrogate who can provide consent.
  • If resident lacks capacity, that resident does not assent with surrogate who provides assent
  • Does not agree to have serologic testing for COVID-19
  • Refuses to agree to remain on one of the facility units of study or to be transferred to such unit

Exclusion

    Key Trial Info

    Start Date :

    August 11 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 4 2022

    Estimated Enrollment :

    87 Patients enrolled

    Trial Details

    Trial ID

    NCT05270980

    Start Date

    August 11 2021

    End Date

    February 4 2022

    Last Update

    April 6 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    ArchCare at Mary Manning Walsh Home (MMW)

    New York, New York, United States, 10021

    2

    ArchCare at Terence Cardinal Cooke Health Care Center (TCC)

    New York, New York, United States, 10029